Can Synopsys (SNPS) Balance AI Ambitions With Earnings Pressure After Latest Student Outreach Push?

• In recent weeks, Synopsys announced the launch of an interactive digital twin racetrack experience for over 400,000 STEM Racing students worldwide, unveiled at the Aramco STEM Racing World Finals in Singapore, and participated in the World Summit AI 2025 in Amsterdam with a keynote by its Distinguished Architect for Machine Learning Architecture.
• This initiative deepens Synopsys' engagement with the next generation of STEM talent, offering complimentary access to advanced simulation tools typically used by professional F1 teams, while new conference presentations highlight its ongoing push into machine learning and AI-enabled design solutions.
• We'll now explore how Synopsys' recent earnings miss and updated guidance for fiscal 2025 shape its investment narrative.

We've found 19 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Synopsys Investment Narrative Recap

To be a shareholder in Synopsys, you are essentially buying into the belief that its expansion into silicon-to-systems engineering, accelerated by the Ansys integration and focus on AI-powered design, can outweigh margin pressures and competitive risks. While the company’s latest digital twin and STEM outreach initiatives keep Synopsys connected to future talent and market trends, they have no material bearing on the most immediate catalysts, restoring earnings momentum and achieving smoother Ansys integration. Currently, execution risks on cost, integration, and market share remain front and center.

Among the many recent announcements, the regulatory clearance and finalization of Synopsys' divestiture of the Optical Solutions Group and PowerArtist businesses to Keysight stand out as most relevant to short-term execution. These transactions were conditions of the Ansys deal, and their expected financial immateriality means investor focus should stay on the core catalyst: successfully capturing cross-selling opportunities, scaling recurring revenues, and demonstrating cost synergy gains post-acquisition.

Yet, while major growth drivers are clear, investors should also be mindful of the ongoing execution and integration risks surrounding the Ansys acquisition, especially as...

Read the full narrative on Synopsys (it's free!)

Synopsys' outlook forecasts $12.1 billion in revenue and $2.7 billion in earnings by 2028. This is based on analysts expecting 24.7% annual revenue growth and an increase in earnings of $1.3 billion from the current $1.4 billion.

Uncover how Synopsys' forecasts yield a $556.40 fair value, a 27% upside to its current price.

Exploring Other Perspectives

Community fair value estimates for Synopsys range from US$421 to US$556, based on seven independent Simply Wall St Community forecasts. Despite this high variability, the most pressing topic remains execution risk on integrating Ansys and achieving expected cost efficiencies going forward.

Explore 7 other fair value estimates on Synopsys - why the stock might be worth as much as 27% more than the current price!

Build Your Own Synopsys Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Synopsys research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Synopsys research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Synopsys' overall financial health at a glance.

Searching For A Fresh Perspective?

Our top stock finds are flying under the radar-for now. Get in early:

• Find companies with promising cash flow potential yet trading below their fair value.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Outshine the giants: these 24 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com